These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2037129)

  • 1. The design of photo-affinity labels for the characterisation of the 5-hydroxytryptamine transporter on human platelet membranes.
    Maher WJ; Phillips OM; Williams DC
    Biochem Soc Trans; 1991 Feb; 19(1):10S. PubMed ID: 2037129
    [No Abstract]   [Full Text] [Related]  

  • 2. Probing the platelet plasma-membrane 5-hydroxytryptamine transporter.
    Williams DC; Phillips OM
    Biochem Soc Trans; 1991 Feb; 19(1):112-4. PubMed ID: 2037132
    [No Abstract]   [Full Text] [Related]  

  • 3. Substrate and inhibitor binding and translocation by the platelet plasma membrane serotonin transporter.
    Humphreys CJ; Beidler D; Rudnick G
    Biochem Soc Trans; 1991 Feb; 19(1):95-8. PubMed ID: 2037207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Approaches to the purification of the 5-hydroxytryptamine reuptake system from human blood platelets.
    Biessen EA; Horn AS; Robillard GT
    Biochem Soc Trans; 1991 Feb; 19(1):103-11. PubMed ID: 2037130
    [No Abstract]   [Full Text] [Related]  

  • 5. 2-Iodoimipramine, a novel ligand for the serotonin transporter.
    Humphreys CJ; Cassel D; Rudnick G
    Mol Pharmacol; 1989 Oct; 36(4):620-6. PubMed ID: 2811859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial characterization of solubilized platelet imipramine binding sites using a new probe, [3H]3-cyanoimipramine ([3H]Ro 11-2465).
    Davis A; Morris JM; Tang SW
    Eur J Pharmacol; 1985 Feb; 109(1):97-104. PubMed ID: 2986992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dithiothreithol promotes a higher affinity state of the serotonin transporter for the tricyclic antidepressant, imipramine.
    Tarrant HM; Williams DC
    Biochem Soc Trans; 1995 Feb; 23(1):41S. PubMed ID: 7758754
    [No Abstract]   [Full Text] [Related]  

  • 8. Binding of [3H]imipramine to human platelet membranes with compensation for saturable binding to filters and its implication for binding studies with brain membranes.
    Phillips OM; Wood KM; Williams DC
    J Neurochem; 1984 Aug; 43(2):479-86. PubMed ID: 6330301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [3H]2-Nitroimipramine: a selective "slowly-dissociating" probe of the imipramine binding site ("serotonin transporter") in platelets and brain.
    Rehavi M; Tracer H; Rice K; Skolnick P; Paul SM
    Life Sci; 1983 Feb; 32(6):645-53. PubMed ID: 6835029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets.
    Plenge P; Mellerup ET; Laursen H
    Eur J Pharmacol; 1991 Mar; 206(3):243-50. PubMed ID: 1830276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2-nitroimipramine: a selective irreversible inhibitor of [3H] serotonin uptake and [3H] imipramine binding in platelets.
    Rehavi M; Ittah Y; Rice KC; Skolnick P; Goodwin FK; Paul SM
    Biochem Biophys Res Commun; 1981 Apr; 99(3):954-9. PubMed ID: 7247951
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet serotonin transporter.
    Rudnick G; Humphreys CJ
    Methods Enzymol; 1992; 215():213-24. PubMed ID: 1435323
    [No Abstract]   [Full Text] [Related]  

  • 13. Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human platelet membranes.
    Mellerup ET; Plenge P; Nielsen M
    Eur J Pharmacol; 1984 Nov; 106(2):411-3. PubMed ID: 6099278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of the platelet plasma membrane serotonin transporter in an active form.
    Talvenheimo J; Rudnick G
    J Biol Chem; 1980 Sep; 255(18):8606-11. PubMed ID: 7410380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [3H]citalopram binding to brain and platelet membranes of human and rat.
    Plenge P; Mellerup ET
    J Neurochem; 1991 Jan; 56(1):248-52. PubMed ID: 1824783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of platelet [3H]-imipramine binding by human plasma protein fractions.
    Strijewski A; Chudzik J; Tang SW
    Life Sci; 1988; 42(16):1543-50. PubMed ID: 3352466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in platelet 3-H-imipramine binding: influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents used.
    Rosel-Soria P; Vallejo J; Oros M; Serrallonga J; Menchon JM; Navarro MA
    Biol Psychiatry; 1995 Oct; 38(7):464-70. PubMed ID: 8672607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High affinity binding of [3H]paroxetine and [3H]imipramine to human platelet membranes.
    Mellerup ET; Plenge P; Engelstoft M
    Eur J Pharmacol; 1983 Dec; 96(3-4):303-9. PubMed ID: 6233162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ligand binding to the serotonin transporter: equilibria, kinetics, and ion dependence.
    Humphreys CJ; Wall SC; Rudnick G
    Biochemistry; 1994 Aug; 33(31):9118-25. PubMed ID: 8049215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term verapamil treatment increases [3H]imipramine binding in human platelets.
    Cohen A; Weizman A; Eldar M; Rehavi M
    Eur J Pharmacol; 1990 Jun; 181(3):311-4. PubMed ID: 2166676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.